Cite
HARVARD Citation
Farrell, K. et al. (n.d.). An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events. Leukemia & lymphoma. 57 (11), pp. 2568-2574. [Online].